| Ytd | 64.18% | |
| 1y | 143.37% |
| Open | 245.81 | Prev Close | 253.08 | Low | 240.08 | High | 250.26 | Mkt Cap | 13.21B |
| Vol | 658.42K | Avg Vol | 1.12M | EPS | 4.73 | P/E | 52.09 | Forward P/E | 19.43 |
| Beta | 1.56 | Short Ratio | 2.67 | Inst. Own | 101.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-27 | 50-d Avg | 238.01 | 200-d Avg | 168.18 | 1yr Est | 223.75 |
Compare sector allocations, risk profiles, and long-term growth potential as these two funds target
HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an
Sanmina is rated buy with a $312 price target, driven by strong ZT Systems integration and accelerat